Back to results list
WEB OF SCIENCETM
Please use this identifier to cite or link to this item:
|Title:||Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome||Authors:||Ou, HT
Health-related quality of life
Polycystic ovary syndrome
|Issue Date:||2016||Publisher:||BioMed Central||Source:||Health and quality of life outcomes, 2016, v. 14, no. 1, 119 How to cite?||Journal:||Health and quality of life outcomes||Abstract:||Background: Few studies have assessed whether the amelioration of the clinical signs of polycystic ovary syndrome (PCOS) achieved by treatment leads to improvement in the health-related quality of life (HRQoL) of patients. This study was aimed to examine the HRQoL of ethnic Chinese women with PCOS who received metformin treatment.
Methods: This prospective study was conducted at a medical center in Taiwan. Study participants aged 18-45 years were diagnosed as having PCOS according to the Rotterdam criteria, and all received metformin treatment. Their HRQoL was assessed using generic (WHOQOL-Bref) and PCOS-specific (Chi-PCOSQ) instruments. Mixed effect models were used to examine the effects of metformin on repeatedly measured HRQoL. Additional analyses using stratified patients characteristics (overweight vs. normal; hyperandrogenism vs. non-hyperandrogenism) were done.
Results: We recruited 109 participants (56 % were overweight, 80 % had hyperandrogenism). Among the domain scores of WHOQOL-Bref, the psychological domain score was the lowest one (12.64±2.2, range 4-20). Weight (3.25±1.59, range 1-7) and infertility (3.38±1.93, range 1-7) domain scores were relatively low among the domain scores of Chi-PCOSQ. Overweight and hyperandrogenic patients had significantly lower HRQoL as compared with those of normal weight and non-hyperandrogenic patients, respectively. Metformin significantly improved the physical domain of WHOQOL-Bref (p=0.01), and the infertility (p=0.043) and acne and hair loss aspects (p=0.008) of PCOS-specific HRQoL. In the subgroup analysis, significantly improved HRQoL following metformin treatment appeared for only overweight and hyperandrogenism subgroups.
Conclusions: Metformin might improve health-related quality of life of polycystic ovary syndrome women by ameliorating psychological disturbances due to acne, hair loss and infertility problems, especially for overweight and hyperandrogenic patients.
|URI:||http://hdl.handle.net/10397/62162||EISSN:||1477-7525||DOI:||10.1186/s12955-016-0520-9||Rights:||This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The following article: Ou, H. T., Chen, P. C., Wu, M. H., & Lin, C. Y. (2016). Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome. Health and quality of life outcomes, 14(1), 119, is available at https//doi.org/10.1186/s12955-016-0520-9
|Appears in Collections:||Journal/Magazine Article|
Show full item record
Files in This Item:
|Ou_Metformin_health-related_quality.pdf||412.66 kB||Adobe PDF||View/Open|
Citations as of Apr 19, 2018
WEB OF SCIENCETM
Citations as of Apr 17, 2018
Citations as of Apr 16, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.